| Alix J Charles, MD | |
|
40 S Clay St Ste Ll30, Hinsdale, IL 60521-3257 | |
| (630) 286-5050 | |
| Not Available |
| Full Name | Alix J Charles |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 24 Years |
| Location | 40 S Clay St Ste Ll30, Hinsdale, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902891377 | NPI | - | NPPES |
| 036109235 | Medicaid | IL | |
| P00631982 | Other | IL | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 036109235 (Illinois) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dupage Medical Group Ltd | 5496667941 | 1209 |
News Archive
An international study released this week in the prestigious journal Nature could revolutionise the way in which cancers are treated and potentially put an end to aggressive DNA damaging chemotherapies and radiotherapy treatments.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced results from a 12-week, placebo-controlled Phase IIb study involving 79 patients with active rheumatoid arthritis ("RA") for its proprietary drug CF101, an A3 adenosine receptor ("A3AR") agonist.
A new study shows cellular-level changes in nerve structure and function that may contribute to the development of migraine headaches, reports the November issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).
A new study by scientists at the Wayne State University School of Medicine demonstrates that communication between some of the brain's most important centers is altered in children with obsessive-compulsive disorder.
› Verified 6 days ago
| Entity Name | Dupage Medical Group Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801833983 PECOS PAC ID: 5496667941 Enrollment ID: O20031110000535 |
News Archive
An international study released this week in the prestigious journal Nature could revolutionise the way in which cancers are treated and potentially put an end to aggressive DNA damaging chemotherapies and radiotherapy treatments.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced results from a 12-week, placebo-controlled Phase IIb study involving 79 patients with active rheumatoid arthritis ("RA") for its proprietary drug CF101, an A3 adenosine receptor ("A3AR") agonist.
A new study shows cellular-level changes in nerve structure and function that may contribute to the development of migraine headaches, reports the November issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).
A new study by scientists at the Wayne State University School of Medicine demonstrates that communication between some of the brain's most important centers is altered in children with obsessive-compulsive disorder.
› Verified 6 days ago
| Entity Name | Adventist Midwest Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962570382 PECOS PAC ID: 4486556727 Enrollment ID: O20040126000676 |
News Archive
An international study released this week in the prestigious journal Nature could revolutionise the way in which cancers are treated and potentially put an end to aggressive DNA damaging chemotherapies and radiotherapy treatments.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced results from a 12-week, placebo-controlled Phase IIb study involving 79 patients with active rheumatoid arthritis ("RA") for its proprietary drug CF101, an A3 adenosine receptor ("A3AR") agonist.
A new study shows cellular-level changes in nerve structure and function that may contribute to the development of migraine headaches, reports the November issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).
A new study by scientists at the Wayne State University School of Medicine demonstrates that communication between some of the brain's most important centers is altered in children with obsessive-compulsive disorder.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alix J Charles, MD Po Box 713260, Chicago, IL 60677-1260 Ph: (630) 469-9200 | Alix J Charles, MD 40 S Clay St Ste Ll30, Hinsdale, IL 60521-3257 Ph: (630) 286-5050 |
News Archive
An international study released this week in the prestigious journal Nature could revolutionise the way in which cancers are treated and potentially put an end to aggressive DNA damaging chemotherapies and radiotherapy treatments.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced results from a 12-week, placebo-controlled Phase IIb study involving 79 patients with active rheumatoid arthritis ("RA") for its proprietary drug CF101, an A3 adenosine receptor ("A3AR") agonist.
A new study shows cellular-level changes in nerve structure and function that may contribute to the development of migraine headaches, reports the November issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).
A new study by scientists at the Wayne State University School of Medicine demonstrates that communication between some of the brain's most important centers is altered in children with obsessive-compulsive disorder.
› Verified 6 days ago
Dr. Gina M Dillig, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 908 N Elm St, Hinsdale, IL 60521 Phone: 630-455-1756 Fax: 630-455-1759 | |
Dr. Louisa K Gehlmann, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 901 N Elm St., Hinsdale, IL 60521 Phone: 630-325-6880 Fax: 630-325-5975 | |
Dr. Stephanie Bayers, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 920 N York Rd Ste 100, Hinsdale, IL 60521 Phone: 312-319-1978 Fax: 312-262-7791 | |
Melanie L Zahner, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 908 N Elm St Ste 300, Hinsdale, IL 60521 Phone: 630-884-5913 Fax: 630-455-1759 | |
Dr. Matthew Nathan Harris, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 333 Chestnut St, Hinsdale, IL 60521 Phone: 630-325-6880 Fax: 630-325-5975 | |
Dr. Christina Gutierrez-steil, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 125 W 2nd St, Hinsdale, IL 60521 Phone: 630-455-0045 Fax: 630-455-0955 | |
Scott L Zahner, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 908 N Elm St Ste 300, Hinsdale, IL 60521 Phone: 630-884-5913 Fax: 630-455-1759 |